An experimental Alzheimer’s drug therapy has slowed cognitive and functional decline by 27% versus placebo in a double-blind, randomized study of 1,795 individuals with early signs and symptoms of the disease.

Patients with autoimmune hepatitis may be better monitored across disease stages by AI-augmented multiparametric MRI than by liver biopsy, as the imaging has proven less costly and is inherently less risky due to its noninvasiveness. 

Social vulnerability index scores account for factors like socioeconomic status, household composition, disability, minority status, language, housing type and transportation.

When exam volumes increase, so too does the risk of diagnostic errors in interpretations, many of which can be clinically significant.

With 91% sensitivity but only 25% specificity, the tool is worthwhile for clinicians who remain wary of frequent false positives that would send patients with no fractures for unneeded imaging.

Experts found that compared to the average effective doses of organs, breast doses were higher, representing increased risks of breast cancer for women. 

A pharmaceutical compound approved 21 years ago to treat breast cancer in postmenopausal women is showing fresh promise as a therapy for glioblastomas. 

The boon comes in the form of greater brain cortical thickness observable on neonatal MRI two weeks after the baby enters the world.